March 7th 2025
Being fully versed on the ins and outs of design quality can improve the project design phase life cycle.
FDA Notifies Genentech of Violations at Avastin Plant
November 10th 2011On Sept. 27, 2011, FDA sent Genentech a Form 483 listing several violations at the company's South San Francisco, California, plant. The violations included problems with investigations into batch failures, inappropriate equipment design, and insufficient protection against contamination. FDA visited the plant, which produces the cancer drug Avastin, 13 times in September 2011 and made four observations.
Focus on Standardisation, Quality by Design and Regulatory GMP
November 1st 2011June and July saw three major US conferences on implementing single-use technologies: the IBC Single-use Applications meeting, the PDA Single-use Workshop and the Bio-Process Systems Alliance (BPSA) International Single-use Summit (ISUS). Jerold Martin highlights some of the key topics discussed at these meetings.
Managing Technology Transfer: Developing a Complete CMC Package for an In-Licensed Product
August 1st 2011The authors share their approach and experience working in complex, multicompany environments for in-licensed products to develop successful chemistry, manufacturing, and controls packages for managing outsourcing partnerships.
Evaluating QbD's Impact on the Outsourced Relationship
August 1st 2011An Industry Roundtable Moderated by Patricia Van Arnum and Rich Whitworh. Contract service and technology providers share their perspectives on the influence of quality by design in the expectations between sponsor companies and outsourcing providers.